AU2002364912A1 - Formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability - Google Patents

Formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability

Info

Publication number
AU2002364912A1
AU2002364912A1 AU2002364912A AU2002364912A AU2002364912A1 AU 2002364912 A1 AU2002364912 A1 AU 2002364912A1 AU 2002364912 A AU2002364912 A AU 2002364912A AU 2002364912 A AU2002364912 A AU 2002364912A AU 2002364912 A1 AU2002364912 A1 AU 2002364912A1
Authority
AU
Australia
Prior art keywords
fenofibrate
formulations
derivatives
oral bioavailability
improved oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002364912A
Inventor
Beth A. Burnside
Scott A. Ibrahim
Amir H. Shojaei
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Supernus Pharmaceuticals Inc
Original Assignee
Shire Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shire Laboratories Inc filed Critical Shire Laboratories Inc
Priority claimed from PCT/US2002/041093 external-priority patent/WO2004002458A1/en
Priority claimed from US10/324,953 external-priority patent/US20040005339A1/en
Publication of AU2002364912A1 publication Critical patent/AU2002364912A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AU2002364912A 2002-06-28 2002-12-20 Formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability Abandoned AU2002364912A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
USNOTGIVEN 1990-08-27
US39280602P 2002-06-28 2002-06-28
US39279102P 2002-06-28 2002-06-28
US60/392,806 2002-06-28
US60/392,791 2002-06-28
PCT/US2002/041093 WO2004002458A1 (en) 2002-06-28 2002-12-20 Formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability
US10/324,953 US20040005339A1 (en) 2002-06-28 2002-12-20 Formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability

Publications (1)

Publication Number Publication Date
AU2002364912A1 true AU2002364912A1 (en) 2004-01-19

Family

ID=30003755

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002364912A Abandoned AU2002364912A1 (en) 2002-06-28 2002-12-20 Formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability

Country Status (2)

Country Link
AU (1) AU2002364912A1 (en)
CA (1) CA2491543A1 (en)

Also Published As

Publication number Publication date
CA2491543A1 (en) 2004-01-08

Similar Documents

Publication Publication Date Title
AU2003258961A1 (en) Self-emulsifying formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability and/or reduced food effect
AU2003235676A1 (en) Tricyclic-bis-enone derivatives and methods of use thereof
AU2003296897A1 (en) Pharmaceutical formulations of camptothecine derivatives
AU2003241477A1 (en) Nanoparticulate polycosanol formulations and novel polycosanol combinations
EP1479666A4 (en) Ester compound and medicinal use thereof
AU2003226189A1 (en) Oral administration of epothilones
AU2002340470A1 (en) L-dopa ethyl ester salts and uses thereof
AU2003205558A1 (en) Thioibotenic acid and derivatives thereof
AU2003277876A1 (en) Modified release formulations of oxcarbazepine and derivatives thereof
AU2003296369A1 (en) Imminoamines and preparation thereof
GB0202900D0 (en) Novel formulations of drugs
AU2003276688A1 (en) Pharmaceutical composition of metaxalone with enhanced oral bioavailability
IL175746A0 (en) Oral formulations of desoxypeganine and uses thereof
AU2002308891A1 (en) Novel heterocyclic derivatives and medicinal use thereof
AU2003297612A1 (en) 2-substituted-3-propenamide derivatives and methods of using the same
EP1539117A4 (en) Formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability
AU2003206872A1 (en) Derivatives of (1-benzyl-piperidine-4-yl)-diphenyl-methanol and their use as pesticide
AU2003284942A1 (en) Oral extended release tablets and methods of making and using the same
AU2003263480A1 (en) Oral pharmaceutical compositions of fenofibrate having high bioavailability
AU2003296871A1 (en) Point feeder and use of point feeder
AU2003900495A0 (en) Aroylhydrazone derivatives and therapeutic uses thereof
AU2002364912A1 (en) Formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability
AU2003240052A1 (en) Il-11 derivatives and therapeutic uses thereof
AU2002343199A1 (en) Formulations of erythromycin derivatives with improved bioavailability
AU2002308105A1 (en) Benzoaxathiepin derivatives and their use as medicines

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase